Search

everythinglearnresearchcommunity

for

Search:↓

PCOS and eating disorders are linked by hormonal imbalances, needing personalized treatment.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Both immature and mature fat cells are important for hair growth cycles, with immature cells promoting growth and mature cells possibly inhibiting it.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Altered lipid pathways in diabetic women may cause premature greying.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

PRP can help treat hair loss but needs standardized methods for best results.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

PRGF is a promising treatment for hair loss with some patient benefits.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Low-molecular weight hyaluronate can make damaged hair stronger.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Low Level Laser Therapy can promote hair growth.

Low-dose UVB light improves hair growth effects of certain stem cells by increasing reactive oxygen species.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Low iron levels in the blood may be linked to chronic hair loss in women.